ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,035,694 | -28.8% | 4,572,977 | -0.0% | 0.02% | -27.6% |
| Q2 2023 | $29,551,826 | -14.9% | 4,574,586 | -0.7% | 0.03% | -17.1% |
| Q1 2023 | $34,745,526 | -16.4% | 4,608,160 | +12.4% | 0.04% | -20.5% |
| Q4 2022 | $41,538,014 | +2.4% | 4,100,495 | -0.0% | 0.04% | -2.2% |
| Q3 2022 | $40,564,000 | +46.8% | 4,101,471 | +58.1% | 0.04% | +55.2% |
| Q2 2022 | $27,625,000 | +6.7% | 2,593,958 | -2.3% | 0.03% | +31.8% |
| Q1 2022 | $25,884,000 | -31.2% | 2,654,714 | +0.9% | 0.02% | +10.0% |
| Q4 2021 | $37,631,000 | -33.0% | 2,631,525 | -6.1% | 0.02% | -35.5% |
| Q3 2021 | $56,160,000 | -3.2% | 2,802,411 | +6.3% | 0.03% | 0.0% |
| Q2 2021 | $57,987,000 | -24.8% | 2,635,773 | +16.1% | 0.03% | -20.5% |
| Q1 2021 | $77,116,000 | – | 2,270,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |